CardioGenics Holdings (CardioGenics Holdings) Additional Paid-In Capital : $47.87 Mil(As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Additional Paid-In Capital?

CardioGenics Holdings's quarterly additional paid-in capital increased from Jul. 2015 ($47.40 Mil) to Oct. 2015 ($47.84 Mil) and increased from Oct. 2015 ($47.84 Mil) to Jan. 2016 ($47.87 Mil).

CardioGenics Holdings's annual additional paid-in capital increased from Oct. 2013 ($44.51 Mil) to Oct. 2014 ($46.51 Mil) and increased from Oct. 2014 ($46.51 Mil) to Oct. 2015 ($47.84 Mil).

CardioGenics Holdings Additional Paid-In Capital Historical Data

The historical data trend for CardioGenics Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Additional Paid-In Capital Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Additional Paid-In Capital

Get a 7-Day Free Trial

41.77

42.04

44.51

46.51

47.84

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Additional Paid-In Capital	Get a 7-Day Free Trial															47.03	47.21	47.40	47.84	47.87

CardioGenics Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

CardioGenics Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines